Lokesh Joshi | OMICS International
ISSN: 2157-2526

Journal of Bioterrorism & Biodefense
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Lokesh Joshi

 Vice President for Research at the National University of Ireland


Professor Joshi’s personal research focuses on the role of complex sugars in health and diseases. He was recruited to Ireland as the Science Foundation Ireland (SFI) Stokes Professor of Glycosciences. He is the Director of the Glycosciences Research group at the National University of Ireland, Galway and is a co-investigator in CÚRAM, the SFI-funded national medical devices research centre. Previously, Professor Joshi was an Associate Professor in the Department of Bioengineering and Director of the Center for Glycoscience and Technologies in the Biodesign Institute at Arizona State University (ASU). He completed postdoctoral and research associate training at Boyce Thompson Institute and Cornell University and received a PhD from Bath University.

Professor Joshi has published more than one hundred articles and has been an active scientist-entrepreneur. He was co-founder of Arizona Engineered Therapeutics. In Ireland he co-founded a Biotech company, Aquila Bioscience, focusing on healthcare solutions.

Research Interest

 Bioengineering, Glycomimetics; Glycoconjugates; Shiga toxin; Cholera toxin; Botulinum toxin; Ebola; Zika; Influenza; DC-SIGN